Journal: Immunity, inflammation and disease
Article Title: Dendritic cells infected with recombinant adenoviral vector encoding mouse fibroblast activation protein-α and human livin α exert an antitumor effect against Lewis lung carcinoma in mice.
doi: 10.1002/iid3.1011
Figure Lengend Snippet: FIGURE 3 The antitumor effect of rAd‐FAP/hlivin α‐transduced DCs on LLC in mice. (A and B) Mice were separately immunized with rAd‐EGFP‐transduced DCs, rAd‐FAP‐transduced DCs, rAd‐hlivin α‐transduced DCs, and rAd‐FAP/hlivin α‐transduced DCs (5 × 105 cells/ mouse) on Day 8 postinjection with LLC cells, and tumor volume (mm3) was calculated every 2 days for a total 24 days. (C) Mouse survival rate was observed for 80 days. (D) Splenic lymphocytes were obtained from mice on Day 7 after receiving injection with rAd‐EGFP‐ transduced DCs, rAd‐FAP‐transduced DCs, rAd‐hlivin α‐transduced DCs or rAd‐FAP/hlivin α‐transduced DCs. The cytotoxic effect of splenic lymphocytes on LLC‐derived CAFs was analyzed using Cytotox96 Non‐Radioactive Cytotoxicity Assay Kit. ***p < .001, versus 1#; +p < .05, +++p < .001, versus 2#; ^p < .05, ^^p < .01, ^^^p < .001, versus 3#. CAFs, cancer‐associated fibroblasts; DCs, dendritic cells; LLC, Lewis lung carcinoma; FAP, fibroblast activation protein‐α; rAd‐FAP, recombinant adenoviral vector encoding mouse FAP cDNA; rAd‐hlivin α, recombinant adenoviral vector encoding human livin α cDNA.
Article Snippet: Following incubation with blocking buffer (P0231, Beyotime), Western blot was performed by incubating the membranes with primary antibodies against FAP (NB110‐85534, 88 kDa, Novus Biologicals), livin α (NB100‐56145, 33 kDa, Novus Biologicals), CD45 (ab10558, 147 kDa, Abcam), CD31 (ab281583, 82 kDa, Abcam), α‐SMA (ab5694, 42 kDa, Abcam), and internal control GAPDH (ab8245, 37 kDa, Abcam) at 4°C overnight.
Techniques: Injection, Derivative Assay, Cytotoxicity Assay, Activation Assay, Recombinant, Plasmid Preparation